UNSPSC 51111764: Vinepidine

This classification denotes a vinca alkaloid compound and vinca-site binding agent with the molecular formula C46H56N4O9, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, W3375J6V0Y chemically known as vincaleukoblastine, 4'-deoxy-22-oxo-, (4'.alpha.)- but generally known as vinepidine, which bears US NIH Compound Identifier 125688. European Medicines Agency schedules Vinepidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00062MIG.

UNSPSC 51111764 Vinepidine, a Commodity code, nominally refers to a specific pharmaceutical product, but recent state and local solicitations tagged with this code show minimal activity directly aligned with the code's stated scope. The limited recent opportunities present a mismatch: a Seminole County, Florida IFB for Naloxone and drug deactivation systems; a Texas HHS Request for Information on direct-to-manufacturer prescription programs; a City of Tampa IFB for medical and first aid supplies for the Fire Department; and a Minnesota cooperative purchasing RFP for generic multi-source pharmaceuticals and OTC products. Only the MMCAP cooperative purchasing opportunity involves pharmaceutical products at scale, while the Seminole County and Tampa solicitations focus on emergency medical supplies and naloxone—neither of which is vinepidine. The issuing bodies span state health agencies (Texas HHS Commission), county governments (Seminole County), cities (Tampa), and cooperative purchasing alliances (MMCAP, administered by Minnesota Department of Administration). The code does not show concentrated activity under a single buyer or jurisdiction type.

Recent activity appears geographically dispersed across Texas, Florida, and Minnesota, with the MMCAP cooperative serving multiple states including Oregon. The most substantive recent opportunity is the Minnesota MMCAP RFP (S1070000015802) for generic multi-source pharmaceuticals and OTC products, due March 26, 2026, which establishes contracts for distribution through three authorized wholesalers with pricing evaluation weighted 75 percent on price competitiveness and vendor evaluation based on cGMP compliance, DSCSA certification, and EDI capability. The City of Tampa IFB (26P00145) for medical and first aid supplies, due March 13, 2026, carries an estimated contract value of $700,000 and is sheltered for certified Small Local Business Enterprises with a 5 percent bid discount. The Seminole County IFB (IFB60459723LAS) seeks 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries, due July 26, 2023, and potentially funded through FEMA. The code shows little recent relevant activity and does not reflect active demand for vinepidine specifically in state and local procurement.